Patent application number | Description | Published |
20090041844 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 02-12-2009 |
20090098202 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 04-16-2009 |
20090130197 | EXTENDED RELEASE PELLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT - An extended release pellet comprising an active ingredient selected from pramipexole and the pharmaceutically acceptable salts thereof, and at least one release-modifying excipient. | 05-21-2009 |
20090252790 | TABLET FORMULATION - The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet. | 10-08-2009 |
20090281153 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 11-12-2009 |
20100168191 | PHARMACEUTICAL FORMULATION COMPRISING PRAMIPEXOLE - The present invention refers to the use of a medicament for the paediatric treatment of RLS and/or Tic Disorder and/or Tourette's Syndrom. | 07-01-2010 |
20100178342 | Solid Pharmaceutical Preparation - The invention relates to a solid pharmaceutical preparation containing one or more solid carriers and/or excipients and an active substance selected from among the Monoamine Neurotransmitter Re-uptake Inhibitors which have a 2,3-disubstituted tropane structure, the preparation thereof and use thereof for preparing a pharmaceutical composition for the treatment or prevention of central-nervous diseases or disorders. | 07-15-2010 |
20110129538 | PROCESS FOR PREPARING ORALLY ADMINISTERED DABIGATRAN FORMULATIONS - The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I | 06-02-2011 |
20110142929 | SOLID PHARMACEUTICAL FORMULATIONS COMPRISING BIBW 2992 - The present invention relates to a pharmaceutical dosage form containing the active substance BIBW 2992 as the dimaleate salt, providing an immediate release profile of the active substance, further, the invention relates to compacted intermediates comprising BIBW 2992 dimaleate salt (BIBW 2992 MA | 06-16-2011 |
20110150994 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 06-23-2011 |
20110195122 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 08-11-2011 |
20110206766 | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION - The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases. | 08-25-2011 |
20120012499 | TABLET FORMULATION - The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet. | 01-19-2012 |
20120282337 | Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole. | 11-08-2012 |
20120282338 | Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof. | 11-08-2012 |
20130251810 | PROCESS FOR PREPARING ORALLY ADMINISTERED DABIGATRAN FORMULATIONS - The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I | 09-26-2013 |
20130274300 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 10-17-2013 |
20130309307 | Bilayer Pharmaceutical Tablet Comprising Telmisartan and a Diuretic and Preparation Thereof - The present invention relates to a bilayer pharmaceutical tablet comprising a first layer formulated for immediate release of the angiotensin II receptor antagonist telmisartan from a dissolving tablet matrix which contains telmisartan in substantially amorphous form, and a second layer formulated for immediate release of a diuretic like hydrochlorothiazide from a fast disintegrating tablet matrix. A method of producing the bilayer tablet is also disclosed. | 11-21-2013 |
20140335175 | Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof - An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. | 11-13-2014 |